Clinical Trials Browser

Phase 1 × Myeloproliferative Disorders × STA 9090 × Clear all

NCT00858572 2014-09-18

STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders

Phase 1 Completed

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Hematologic Neoplasms